Nonsteroidal anti-inflammatory drugs may prevent colon cancer through suppression of hepatocyte growth factor expression

European Journal of Pharmacology

Volumn 367, Issue 1, 1999, Pages 131-138

  Ota, Shinichi ^a   Tanaka, Yasuhiro ^a   Bamba, Hiromi ^a   Kato, Akira ^a   Matsuzaki, Fukashi ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Colon cancer; Hepatocyte growth factor; NSAID (nonsteroidal anti inflammatory drug); Prostaglandin

Indexed keywords

8 BROMO CYCLIC AMP; CHOLERA TOXIN; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; INTERLEUKIN 1BETA; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E1; PROSTAGLANDIN E2; SCATTER FACTOR;

ARTICLE; CANCER PREVENTION; COLON CANCER; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROBLAST; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ALPROSTADIL; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELL SURVIVAL; CELLS, CULTURED; CHOLERA TOXIN; COLON; COLONIC NEOPLASMS; CYCLIC AMP; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DINOPROSTONE; FIBROBLASTS; GENE EXPRESSION; HEPATOCYTE GROWTH FACTOR; HUMANS; INDOMETHACIN; INTERLEUKIN-1; ISOENZYMES; MEMBRANE PROTEINS; MUCOUS MEMBRANE; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROSTAGLANDINS; RECEPTORS, PROSTAGLANDIN E; RNA, MESSENGER;

EID: 0033042033     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00943-1     Document Type: Article

References (33)

1. Akarasereenont P., Thiemermann C. The induction of cyclooxygenase-2 in pulmonary epithelial cell culture (A549) activated by IL1-β is inhibited by tyrosine kinase inhibitors. Biochem. Biophys. Res. Commun. 220:1996;181-185.
2. Bamba H., Ota S., Kato A., Matsuzaki F. Nonsteroidal anti-inflammatory drugs may delay the repair of gastric mucosa by suppressing prostaglandin-mediated increase of hepatocyte growth factor production. Biochem. Biophys. Res. Commun. 245:1998;567-571.
3. Bastin L., Sayer N., Grygorczk R., Metters K.M., Adam M.A. Cloning, functional expression and characterization of the human prostaglandin E2 receptor EP2 subtype. J. Biol. Chem. 269:1994;11873-11877.
4. Ben-Av P., Crofford L.J., Wilder R.L., Hla T. Induction of vascular endothelial growth factor expression in synovial fibroblasts by prostaglandin E and interleukin-1: a potential mechanism for inflammatory angiogenesis. FEBS Lett. 372:1995;83-87.
5. Blaschke V., Jungermann K., Puschel G.P. Exclusive expression of the Gs-linked prostaglandin E2 receptor subtype 4 mRNA in human mononuclear Jurkat and KM-3 cells and coexpression of subtype 4 and 2 in U-937 cells. FEBS Lett. 394:1996;39-43.
6. Camps J.L., Chang S.M., Hsu T.C., Freeman M.R., Hong S.J., Zau H.E., Von Elschenbach A.C., Chung L.W.K. Fibroblast-mediated acceleration of human epithelial tumor growth in vivo. Proc. Natl. Acad. Sci. USA. 87:1990;75-79.
7. Coleman, R.A., Kennedy, I., Hunphrey, P.P.A., Bunce, K., Lumley, P., 1990. Prostanoids and their receptors. In: Emmer, J.C. (Ed.), Comprehensive Medicinal Chemistry: Vol. 3. Membrane and Receptors. Pergamon, Oxford, UK, pp. 643-714.
8. Di Renzo M.F., Narsimhan R.P., Olivero M., Bretti M., Giordano S., Medico E., Gaglia P., Zara P., Comoglio P.M. Expression of the Met/HGF receptor in normal and neoplastic human tissue. Oncogene. 6:1991;1997-2003.
9. Eberhart C.E., Coffey R.J., Radhika A., Gardiello F.M., Ferrenbach S., Dubois R.N. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinoma. Gastroenterology. 107:1994;1183-1188.
10. Giardiello F.M., Hamilton S.R., Krush A.J., Piantadosi S., Hylind L.M., Celano P., Booker S.V., Robinson C.R., Offerhaus J.A. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. New Engl. J. Med. 328:1993;1313-1316.
11. Herschman H.R. Regulation of prostaglandin synthetase-1 and prostaglandin synthetase-2. Cancer Metastasis Rev. 13:1994;241-256.
12. Iwazawa T., Shiozaki H., Doki Y., Inoue M., Tamura S., Matsui S., Monden T., Matsumoto K., Nakamura T., Monden M. Primary human fibroblasts induce diverse tumor invasiveness. Involvement of HGF as an important paracrine factor. Jpn. J. Cancer Res. 87:1996;1134-1142.
13. Jacoby R.F., Marshal D.J., Newton M.A., Novacovic K., Tutsch K., Cole C.E., Lubet R.A., Kelloff G.J., Verma A., Moser A.R., Dove W.F. Chemoprevention of spontaneous intestinal adenomas in the APC Min mouse model by nonsteroidal anti-inflammatory drug piroxicam. Cancer Res. 56:1996;710-714.
14. Kargman S.L., O'Neil G.P., Vickers P.J., Evans J.F., Mancili J.A., Jothy S. Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer. Cancer Res. 55:1995;2556-2559.
15. Kermorgant S., Cardiot G., Levin M.J., Lehy T. Expression of hepatocyte growth factor and its receptor, C-MET in digestive tissues and different gastric and colonic cancer cell lines. Gastroenterol. Clin. Biol. 20:1996;438-445.
16. Matsumoto K., Okazaki H., Nakamura T. Up-regulation of hepatocyte growth factor gene expression by interleukin-1 in human skin fibroblasts. Biochem. Biophys. Res. Commun. 188:1992;235-243.
17. Matsumoto K., Okazaki H., Nakamura T. Novel function of prostaglandins as inducers of gene expression of HGF and putative mediators of tissue regeneration. J. Biochem. 117:1995;458-464.
18. Moser A.R., Pitot H.C., Dove R.F. A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science. 247:1990;322-325.
19. Nursat A., Parkos C.A., Bacarra A.E., Godowski P.J., Delp-Archer C., Rosen E.M., Madara J.L. Hepatocyte growth factor/scatter factor effects on epithelia. Regulation of intercellular junctions in transformed and nontransformed cell lines, basolateral polarization of c-met receptor in transformed and natural intestinal epithelia, and induction of rapid wound repair in a transformed model epithelium. J. Clin. Invest. 93:1994;2056-2065.
20. Δ716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell. 87:1996;803-809.
21. Rao C.V., Rivenson A., Simi B., Zang E., Kelloff G., Steele V., Reddy B.S. Chemoprevention of colon carcinogenesis by sulindac, a nonsteroidal anti-inflammatory drug. Cancer Res. 55:1995;1464-1472.
22. Reddy B.S., Maruyama H., Kelloff G. Dose-related inhibition of colon carcinogenesis by dietary piroxicam, a nonsteroidal anti-inflammatory drug, during different stages of rat colon tumor development. Cancer Res. 47:1987;5340-5346.
23. Reddy B.S., Nayini J., Tokumo K., Rigotty J., Zang E., Kelloff G. Chemoprevention of colon carcinogenesis by concurrent administration of piroxicam, a nonsteroidal anti-inflammatory drug with D,L-alpha-difluoromethylornithine, an ornithine decarboxylase inhibitor, in diet. Cancer Res. 50:1990;2562-2568.
24. Reddy B.S., Tokumo K., Kulkarni N., Aligia C., Kelloff G. Inhibition of colon carcinogenesis by prostaglandin synthesis inhibitors and related compounds. Carcinogenesis. 13:1992;1019-1023.
25. Reddy B.S., Rao C.V., Rivenson A., Kelloff G. Inhibitory effect of aspirin on azoxymethane-induced colon carcinogenesis in F344 rats. Carcinogenesis. 14:1993;1493-1497.
26. Regan J.W., Bailey T.J., Pepperl D.J., Pierce K.L., Bogardus A.M., Donello J.E., Fairbairn C.E., Kedzie K.M., Woodward D.F., Gil D.W. Cloning of a novel human prostaglandin receptor with characteristics of the pharmacologically defined EP2 subtype. Mol. Pharmacol. 46:1994;213-220.
27. Rigas B., Goldman I.S., Levine L. Altered eicosanoid levels in human colon cancer. J. Lab. Clin. Med. 122:1993;518-523.
28. Schiff S.J., Quiao L., Tsai L.L., Rigas B. Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis on HT-29 colon adenocarcinoma cells. J. Clin. Invest. 96:1995;491-503.
29. Sunitha I., Meighen D.L., Hartman D., Thompson E.W., Byers S.W., Avigan M.I. Hepatocyte growth factor stimulates invasion across reconstituted basement membranes by a new human small intestinal cell line. Clin. Exp. Metastasis. 12:1994;143-154.
30. Soeth E., Roder C., Juhl H., Kruger U., Kremer B., Kalthoff H. The detection of disseminated tumor cells in bone marrow from colorectal-cancer patients by a cytokeratin-20-specific nested reverse-transcriptase-chain reaction is related to the stage of disease. Int. J. Cancer. 69:1996;278-282.
31. Takahashi M., Ota S., Hata Y., Mikami Y., Azuma N., Nakamura T., Terano A., Omata M. Hepatocyte growth factor as a key to modulate anti-ulcer action of prostaglandins in stomach. J. Clin. Invest. 98:1996;2604-2611.
32. Thun M.J., Namboodiri M.M., Heath C.W.J. Aspirin use and reduced risk of fatal colon cancer. New Engl. J. Med. 325:1991;1593-1596.
33. Tsujii M., Dubois R.N. Alterations in cellular adhesion and apoptosis in epithelial cells over expressing prostaglandin endoperoxide synthase 2. Cell. 83:1995;493-501.